We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
101
Increased
2,575
Reduced
1,196
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Marker Therapeutics
MRKR
$19.3M
| $626K | ﹤0.01% |
426,169
+36,850
| +9% | +$53.7K |
|
3677
Offerpad Solutions
OPAD
$20.5M
| $614K | ﹤0.01% |
124,364
+7,994
| +7% | +$53.5K |
|
3678
374Water
SCWO
$43.6M
| $613K | ﹤0.01% |
322,788
| – | – |
|
|
SLSN
3679
Solesence Inc
SLSN
$60.1M
| $610K | ﹤0.01% |
830,508
+18,797
| +2% | +$23.2K |
|
3680
Stran & Co
SWAG
$35M
| $609K | ﹤0.01% |
273,239
+5,934
| +2% | +$11.2K |
|
|
MRDN
3681
Meridian Holdings Inc
MRDN
$179M
| $609K | ﹤0.01% |
43,755
+17,452
| +66% | +$182K |
|
3682
Alset
AEI
$68.8M
| $608K | ﹤0.01% |
421,880
-1,573
| -0.4% | -$2.5K |
|
3683
ESS Tech
GWH
$21.3M
| $607K | ﹤0.01% |
638,920
+4,200
| +0.7% | +$4.18K |
|
|
ACTU
3684
Actuate Therapeutics
ACTU
$24.9M
| $602K | ﹤0.01% |
393,433
-7,096
| -2% | -$16.4K |
|
3685
Brilliant Earth
BRLT
$20.8M
| $592K | ﹤0.01% |
524,321
| – | – |
|
3686
ABVC BioPharma
ABVC
$21.9M
| $592K | ﹤0.01% |
374,499
+183,925
| +97% | +$229K |
|
3687
Senti Biosciences Holdings
SNTI
$13.3M
| $591K | ﹤0.01% |
537,504
| – | – |
|
3688
Lipocine
LPCN
$17.3M
| $591K | ﹤0.01% |
230,823
+30,155
| +15% | +$72.5K |
|
3689
IRIDEX
IRIX
$16.4M
| $589K | ﹤0.01% |
514,593
| – | – |
|
|
FLD
3690
Fold Holdings
FLD
$24.8M
| $578K | ﹤0.01% |
1,275,989
-463,675
| -27% | -$500K |
|
|
HIT
3691
Health In Tech Inc
HIT
$65.5M
| $574K | ﹤0.01% |
568,475
+3,000
| +0.5% | +$3.73K |
|
|
ILLR
3692
Triller Group Inc
ILLR
$18M
| $566K | ﹤0.01% |
+208,981
| New | +$499K |
|
3693
Good Times Restaurants
GTIM
$16.4M
| $566K | ﹤0.01% |
401,456
+6,039
| +2% | +$7.74K |
|
3694
Flux Power
FLUX
$15.3M
| $565K | ﹤0.01% |
653,007
| – | – |
|
3695
Beneficient
BENF
$33.8M
| $565K | ﹤0.01% |
153,491
+3,491
| +2% | +$12.1K |
|
3696
CEL-SCI Corp
CVM
$27.6M
| $565K | ﹤0.01% |
543,079
+299,434
| +123% | +$656K |
|
3697
Upland Software
UPLD
$13.9M
| $562K | ﹤0.01% |
120,376
-1
| -0% | -$7 |
|
3698
AYTU BioPharma
AYTU
$25.5M
| $561K | ﹤0.01% |
261,146
| – | – |
|
3699
Harte-Hanks
HHS
$30.3M
| $560K | ﹤0.01% |
259,036
| – | – |
|
|
DBGI
3700
Digital Brands Group
DBGI
$7.3M
| $559K | ﹤0.01% |
18,553
+10,649
| +135% | +$502K |
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.1%. Vanguard Capital Management opened 101 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 101 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.